Skip to content

The Clinical Application of Esketamine Combined with Propofol in Painless Hysteroscopy

The Clinical Application of Esketamine Combined with Propofol in Painless Hysteroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099255
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial disease

Interventions

0.3mg/kg ketamine+2-2.5mg/kg propofol :0.3mg/kg ketamine+2-2.5mg/kg propofol anesthesia induction. When sufficient sedation is achieved [MOAA/S score = 1], a laryngeal mask is inserted, followed by hy
0.4mg/kg ketamine+2-2.5mg/kg propofol :0.4mg/kg ketamine+2-2.5mg/kg propofol anesthesia induction. When sufficient sedation is achieved [MOAA/S score = 1], a laryngeal mask is inserted, followed by hy
0.5mg/kg ketamine+2-2.5mg/kg propofol :0.5mg/kg ketamine+2-2.5mg/kg propofol anesthesia induction. When sufficient sedation is achieved [MOAA/S score = 1], a laryngeal mask is inserted, followed by hy

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.All patients who require painless hysteroscopy for diagnosis and treatment and are willing to undergo it; 2.ASA levels 1-3; 3.The patient has good treatment compliance; 4.Mentally normal, able to communicate normally; 5.Clear understanding, voluntary participation in research, and signing of informed consent form; 6.18<=BMI<=30kg/m^2.

Exclusion criteria

Exclusion criteria: There are contraindications to esketamine, such as hyperthyroidism, glaucoma, and macroangioma, hypertension is poorly controlled or untreated (systolic/diastolic blood pressure exceeds 180/100mmHg at rest, and severe cardiopulmonary, liver or kidney dysfunction, diabetes, and other metabolic diseases, long-term hormone use, drug or alcohol abuse history, or mental illness. Patients receiving emergency surgery and those who are allergic to active ingredients or excipients of drugs in this study are excluded.

Design outcomes

Primary

MeasureTime frame
NRS score;

Secondary

MeasureTime frame
Hypotension incidence rate;Incidence of bradycardia;Anesthesia induction duration;Wake up duration;Duration of stay in the recovery room;Induced additional drug frequency;Maintain the frequency of additional medication;Intraoperative and postoperative adverse events;Patient satisfaction;Postoperative anxiety and sleep status;

Countries

China

Contacts

Public ContactXuan Zhao

Shanghai Tenth People's Hospital

zhaoxuan301@tongji.edu.cn+86 130 5208 2279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026